Company Overview: Athero Nova

Industry News

13 Jan

SeeThruEquity Initiates Research Coverage on AtheroNova, Inc. (AHRO)

AtheroNova, Inc. : SeeThruEquity, a leading New York City based independent equity research and corporate access firm focused on smallcap and microcap public companies, today announced that it has initiated coverage on AtheroNova, Inc. (OTCQB: AHRO), a biotechnology company focused on the discovery, research, development and licensing of novel...

Read more

19 Sep

AtheroNova (AHRO) to Present at the 2013 Aegis Healthcare Conference in Las Vegas

AtheroNova Inc. (AHRO), a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque and improve lipid profiles in humans, today announced that Chairman and CEO, Thomas W. Gardner, will present a corporate overview at the 2013 Aegis Capital Healthcare Conference. The presentation will...

Read more

Enter your email address to receive notifications of new posts by email.

Latest Tweets


Follow this blog

Get every new post delivered right to your inbox.

Email address